Yu, J.; Laborde, J.M.; Park, R.; Shahzad, M.; Kim, Y.; Cheon, J.; Imanirad, I.; Kim, R.D.; Biachi de Castria, T.; Nardella, N.L.;
et al. Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. Cancers 2025, 17, 1797.
https://doi.org/10.3390/cancers17111797
AMA Style
Yu J, Laborde JM, Park R, Shahzad M, Kim Y, Cheon J, Imanirad I, Kim RD, Biachi de Castria T, Nardella NL,
et al. Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. Cancers. 2025; 17(11):1797.
https://doi.org/10.3390/cancers17111797
Chicago/Turabian Style
Yu, James, Jose M. Laborde, Robin Park, Moazzam Shahzad, Youngchul Kim, Jaekyung Cheon, Iman Imanirad, Richard D. Kim, Tiago Biachi de Castria, Nicole L. Nardella,
and et al. 2025. "Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy" Cancers 17, no. 11: 1797.
https://doi.org/10.3390/cancers17111797
APA Style
Yu, J., Laborde, J. M., Park, R., Shahzad, M., Kim, Y., Cheon, J., Imanirad, I., Kim, R. D., Biachi de Castria, T., Nardella, N. L., Malafa, M., Denbo, J. W., Fleming, J. B., Hoffe, S. E., Frakes, J. M., Sinnamon, A. J., Pimiento, J. M., Hodul, P. J., & Kim, D. W.
(2025). Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. Cancers, 17(11), 1797.
https://doi.org/10.3390/cancers17111797
